Diabetes mellitus type 2 post Covid 19

Crossmark: check for updates

Authors

  • Regina Cruz Curiel Undergraduate students in the Medical and Surgical Degree Program at the Institute of Health Sciences (ICSA-UAEH) of the Autonomous University of the State of Hidalgo, Mexico https://orcid.org/0009-0000-4357-2656
  • Beatriz Adriana Vázquez Pérez Centro Universitario de Ciencias de a Salud [CUCS] Universidad de Guadalajara, Jalisco, México https://orcid.org/0009-0009-3268-3276
  • Julieta Aleli Izquierdo Vega Academic Division of Medicine and Master’s Program in Biomedical Sciences (ICSA-UAEH), Institute of Health Sciences at the Autonomous University of the State of Hidalgo, Mexico https://orcid.org/0000-0002-9639-9524
  • Ana Yareli Escudero Castelán Department of Psychology at the Institute of Health Sciences (ICSA-UAEH) of the Autonomous University of the State of Hidalgo, Mexico https://orcid.org/0000-0001-6466-1578
  • Olga Rocío Flores Chávez Department of Nursing at the (ICSA-UAEH) Institute of Health Sciences at the Autonomous University of the State of Hidalgo, Mexico https://orcid.org/0000-0001-9479-9834
  • Josefina Reynoso Vázquez Department of Pharmacy and MSP Coordination at the (ICSA-UAEH) Institute of Health Sciences of the Autonomous University of the State of Hidalgo, Mexico https://orcid.org/0000-0002-9943-0881
  • David Pérez Becker Undergraduate students in the Medical and Surgical Degree Program at the Institute of Health Sciences (ICSA-UAEH) of the Autonomous University of the State of Hidalgo, Mexico https://orcid.org/0009-0007-7554-1310
  • Zabdy Anahí Dimas Ibarra Undergraduate students in the Medical and Surgical Degree Program at the Institute of Health Sciences (ICSA-UAEH) of the Autonomous University of the State of Hidalgo, Mexico https://orcid.org/0009-0009-8736-3181
  • Giselle Lugo Ambrosio Undergraduate students in the Medical and Surgical Degree Program at the Institute of Health Sciences (ICSA-UAEH) of the Autonomous University of the State of Hidalgo, Mexico https://orcid.org/0009-0002-3583-020X
  • Valeria González García Undergraduate students in the Medical and Surgical Degree Program at the Institute of Health Sciences (ICSA-UAEH) of the Autonomous University of the State of Hidalgo, Mexico https://orcid.org/0009-0002-0408-1218
  • Jesús Carlos Ruvalcaba Ledezma 7Independent Researcher, Former Researcher, Academic Division of Medicine, UAEH-MSP, Mexico https://orcid.org/0000-0002-5593-3946

DOI:

https://doi.org/10.17140/phoj-11-770

Keywords:

COVID-19, Diabetes Mellitus Type 2

Abstract

Type 2 diabetes mellitus is a very common disease in Mexican society; it is difficult to control due to poor dietary habits and a lack of adequate treatment. In this article, we will discuss whether the COVID-19 virus is a trigger for type 2 diabetes mellitus. It is known that in some people, a COVID-19 infection can affect blood glucose levels, but is it really a trigger for developing diabetes?

Objective. To determine how type 2 diabetes mellitus might manifest as a post-COVID-19 condition. Methodology. An observational, descriptive, cross-sectional epidemiological study was conducted using a questionnaire created in Google Forms, administered to individuals who had contracted COVID-19 and who have been diagnosed with type 2 diabetes mellitus. Results.  The results of the survey administered to 38 people indicate that 94.7% of our sample population has type 2 diabetes mellitus. Furthermore, we found that the most common age was 76 years, accounting for 15.8% of the sample, while the least common age was 22 years, accounting for 1.6%. Upon questioning our participants, we discovered that 82.9% had been diagnosed with diabetes before the COVID-19 pandemic and that 78.9% contracted COVID-19 between 2020 and 2022. Conclusions. Type 2 diabetes mellitus is one of the leading causes of death in our country; a large portion of the population suffers from this disease from an early age, making it difficult to establish a link between type 2 diabetes mellitus and COVID-19 as a complication.

References

Valero-Cedeño N. ¿Diabetes post COVID-19? Inves-tigación Clínica [Internet]. 2022 [Citado 23 marzo 2025]. Disponible en: https://ve.scielo.org/ scielo.php?script=sci_arttext&pid=S053 5-51332022000100001

Sullivan B. ¿Puede la COVID-19 causar diabetes? Esto es lo que necesitas saber [Internet]. Na-tional Geographic. 2021 [Citado 23 marzo 2025]. Disponible en: https://www.nationalgeogra phic.es/ciencia/2021/06/puede-la-covid -19-causar-diabetes-esto-es-lo-que-nec esitas-saber

Azriel-Mira S. Nuevo diagnóstico de diabetes en pacientes con Covid-19 ¿Cuál es la evidencia? -Revista Diabetes [Internet]. Revista Diabetes. 2022 [Citado 23 marzo 2025]. Available from: https: //www.revistadiabetes.org/investigacio n/nuevo-diagnostico-de-diabetes-en-pac ientes-con-covid-19-cual-es-la-evidenc ia/

Wyne K. The Ohio State University Wexner Medical Center [Internet]. Osu.edu. 2021. Disponible en: https://wexnermedical.osu.edu/our-sto ries/why-are-people-developing-diabete s-after-having-covid19

Ssentongo P, Zhang Y, Witmer L. Association of COVID-19 with diabetes: a systematic review and meta-analysis. [Internet] 2022 [Citado 23 marzo 2025]. Disponible en: https://doi.org/10.1 038/s41598-022-24185-7

Batista-Roche JL, Mirabent-Casals M, Manzanares D, Lund G, García-Gasca A. New-Onset Diabetes Mellitus after COVID-19: Combined Effects of SARS-CoV-2 Variants, Molecular Mimicry, and m6A RNA Methylation. COVID-MDPI. 2024, 4, 481–494. [Citado 23 marzo 2025]. Disponible en: https: //doi.org/10.3390/covid4040032

Revistadiabetes.org. [citado el 13 de mayo de 2025]. Disponible en: https://www.revistadia betes.org/wp-content/uploads/Art.-6.-R Public Health | NAAS Rating (2026): 5.00 ev_69_Actualidda_Nuevo-diagnostico-Dra .-Azriel-OK.pdf

Kim SH, Arora I, Hsia DS, Knowler WC, LeBlanc E, Mylonakis E, et al. New-onset diabetes af-ter COVID-19. J Clin Endocrinol Metab [Internet]. 2023;108(11):e1164–74. Available from: http:// dx.doi.org/10.1210/clinem/dgad284

Oscar RL-G. Importancia del diagnóstico de di-abetes mellitus tipo 2 post COVID-19 [Internet]. Com.mx. [cited 2025 May 13]. Available from: ht tps://www.imbiomed.com.mx/articulo.php ?id=118195

Chandrashekhar Joshi S, Pozzilli P. COVID-19 induced Diabetes: A novel presenta-tion. Diabetes Res Clin Pract [Internet]. 2022;191(110034):110034. Available from: 022.110034

CDC. La diabetes y el sistema inmunitario [Inter-net]. Atlanta: Centers for disease Control and Pre-vention; 2024 [cited 2026 August 14]. Available from: https://www.cdc.gov/diabetes/es/ diabetes-complications/la-diabetes-y-e l-sistema-inmunitario.html

American Diabetes Association Professional Prac-tice Committee. 2. Diagnosis and classification of diabetes: Standards of Care in Diabetes—2026. Di-abetes Care. 2026; 49 (Suppl 1): S27-S49. https: //doi.org/10.2337/dc26-S002

Instituto Nacional de Estadística y Geografía. Es-tadísticas de Defunciones Registradas (EDR) 2023 [Internet]. Aguascalientes: INEGI; 2024 [citado 14 agosto 2026]. Disponible en: https://www.ineg i.org.mx/contenidos/saladeprensa/bolet ines/2024/EDR/EDR2023_ene-dic.pdf

Sun H Kim, Ipsa Arora, Daniel S Hsia, William C Knowler, Erin LeBlanc, Eleftherios Mylon-akis, Richard Pratley, Anastassios G Pittas. New-Onset Diabetes After COVID-19. J Clin Endocrinol Metab. 2023 May 19;108(11):e1164–e1174. doi: 10.1210/clinem/dgad284. Available in: https: //pmc.ncbi.nlm.nih.gov/articles/PMC1 1009784/ ISSN: 2472-3878 | Vol 11 | Issue 1 | 2026

Downloads

Published

2026-07-24 — Updated on 2026-09-17

Versions

How to Cite

Regina Cruz Curiel, Beatriz Adriana Vázquez Pérez, Julieta Aleli Izquierdo Vega, Ana Yareli Escudero Castelán, Olga Rocío Flores Chávez, Josefina Reynoso Vázquez, … Jesús Carlos Ruvalcaba Ledezma. (2026). Diabetes mellitus type 2 post Covid 19. Public Health - Open Journal, 11(1), 773. https://doi.org/10.17140/phoj-11-770 (Original work published July 24, 2026)

Issue

Vol. 11 No. 1 (2026): Volume 11 Issue 1 2026

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All content published in Public Health - Open Journal (PHOJ) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.